Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
Conditions: Cutaneous T-cell Lymphoma; T-Prolymphocytic Leukemia; T-Large Granulocytic Leukemia; T-Lymphoblastic Leukemia/Lymphoma; Peripheral T-Cell Lymphoma
Interventions: Drug: Romidepsin; Drug: Busulfan; Drug: Fludarabine; Procedure: Stem Cell Transplant; Drug: Thymoglobulin
Sponsors: M.D. Anderson Cancer Center; Celgene Corporation
Recruiting - verified January 2017
Interventions: Drug: Romidepsin; Drug: Busulfan; Drug: Fludarabine; Procedure: Stem Cell Transplant; Drug: Thymoglobulin
Sponsors: M.D. Anderson Cancer Center; Celgene Corporation
Recruiting - verified January 2017